FOI release
Yellow Card Reports for Emollient and Barrier Preparations (2021–present)
Some or all of the information requested may not have been provided because we required clarification from the requester.
Case reference FOI2026/00456
Received 26 April 2026
Published 11 June 2026
Request
I am writing to request information under the Freedom of Information Act 2000. Please provide a statistical summary of all Yellow Card reports (including suspected adverse drug reactions and, where applicable, medical device incident reports) relating to products within the BNF category “Emollient and Barrier Preparations” for the period 1 January 2021 to the date of this request. I would prefer this information to be provided in a machine-readable format (e.g. CSV or Excel). To support understanding of patterns and trends in patient-reported outcomes, I would be grateful if the data could be provided in an aggregated format (rather than case-level data) including the following, where available: * Product or brand name * Number of reports per product, broken down by year * Reaction term (using MedDRA terminology), with counts per term * Outcome/severity categories (e.g. fatal, life-threatening, hospitalisation, medically significant, non-serious), with counts * Reporter type (e.g. patient, general practitioner, specialist), with counts In addition, I would be particularly interested in reports indicating that a product may have been ineffective or associated with worsening of the underlying condition. If available, please include: * Counts of reports coded with terms such as “condition aggravated”, “drug ineffective”, “treatment failure”, or similar MedDRA terms indicating lack of efficacy or worsening symptoms Where recorded and extractable, I would also be grateful for: * Any available information on suspected active substances and/or excipients associated with reports (for example paraffin, sodium lauryl sulfate, or isopropyl myristate) If it is not possible to extract data by excipient, I would be content to receive the data by product name only.
Response
See attached
Documents
This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.